fda pulling tirzepatide US judge sides with FDA's removal of Lilly's weight loss drug from shortage list FDA Clarifies Compounding Rules as
Description
Learn why this regulatory shift matters for millions.

Compounding pharmacies and investors have brought legal challenges to enjoin the FDA from enforcing the changes to the shortage list, but have so far been unsuccessful

The clinical alarm bells are calibrated for that reason

Zepbound lawsuit claims center on allegations that the drug may be linked to serious adverse health outcomes
But eliminating it is entirely another ordeal
